首页 产品目录 分子砌块 按反应类型 五元杂环胺化 硫酸4-氨基-2-((4,6-二氨基-3-((3-氨基-6-(氨甲基)-5-羟基四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,5-二醇

硫酸4-氨基-2-((4,6-二氨基-3-((3-氨基-6-(氨甲基)-5-羟基四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,5-二醇

4-amino-2-((4,6-diamino-3-((3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol sulfate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

79645-27-5

中文名称

硫酸4-氨基-2-((4,6-二氨基-3-((3-氨基-6-(氨甲基)-5-羟基四氢-2H-吡喃-2-基)氧基)-2-羟基环己基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,5-二醇

英文名称

4-amino-2-((4,6-diamino-3-((3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol sulfate

别名

1294492-03-7 | AKOS015895163 | BCP12890 | FT-0652844 | 4-AMINO-2-[4,6-DIAMINO-3-[3-AMINO-6-(AMINOMETHYL)-5-HYDROXYOXAN-2-YL]OXY-2-HYDROXYCYCLOHEXYL]OXY-6-(HYDROXYMETHYL)OXANE-3,5-DIOL SULFATE | HMS3371O08 | AC-4512 | 4-amino-2-[4,6-diamino-3-[3-amino-6-(a

标准英文名

4-amino-2-((4,6-diamino-3-((3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol sulfate

MDL No.

MFCD00133864

分子式

C18H39N5O13S

分子量

565.60

精确分子量

565.23

SMILES

NCC1OC(OC2C(N)CC(N)C(OC3OC(CO)C(O)C(N)C3O)C2O)C(N)CC1O.O=S(=O)(O)O

标准SMILES

NCC1OC(OC2C(O)C(OC3OC(CO)C(O)C(N)C3O)C(N)CC2N)C(N)CC1O.OS(O)(=O)=O

用途

Tobramycin sulfate is an aminoglycoside antibiotic used for the treatment of infections caused by susceptible Gram-negative bacteria, particularly Pseudomonas aeruginosa (including gentamicin-resistant strains), Escherichia coli, Klebsiella spp., Enterobacter spp., Proteus spp. (indole-positive and indole-negative), Citrobacter spp., and Providencia spp. Its clinical applications include: 1. Moderate to severe infections due to Enterobacteriaceae and other Gram-negative bacilli; 2. Moderate to severe Pseudomonas aeruginosa infections, often in combination with antipseudomonal β-lactams or other antibiotics; 3. Adjunctive therapy (not first-line) for serious Staphylococcus or Enterococcus infections, such as Pseudomonas aeruginosa infections outside the central nervous system and sepsis, lower respiratory tract infections, intra-abdominal infections, skin and soft tissue infections, and bone infections caused by susceptible organisms.

InChIKey

ZEUUPKVZFKBXPW-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  79645-27-5 逆合成路线 1

—
—
ACWKGZ897
79645-27-5
来源: SureRoute

2.  79645-27-5 逆合成路线 2

—
—
ACWKGZ897
79645-27-5
来源: SureRoute

3.  79645-27-5 逆合成路线 3

—
—
ACWKGZ897
79645-27-5
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手